Evaluating Thrombectomy Devices and Combination Therapies in Acute ischemic Stroke: A systematic review & Network Meta-Analysis of 201 studies

Annu Gulia,Manyata Srivastava,Manabesh Nath,Shubham Misra Jr.,Kamalesh Kumar Patel,Ashish Datt Upadhyay,Deepti Vibha,Shashvat Desai,Pradeep Kumar
DOI: https://doi.org/10.1101/2024.10.24.24316030
2024-10-27
Abstract:Background and Objective: Mechanical Thrombectomy (MT) has become the standard treatment for acute ischemic stroke (AIS) caused by large vessel occlusion (LVO). However, the relative efficacy and safety of different MT devices remain uncertain. This study aims to evaluate and compare the safety and efficacy of different thrombectomy devices and combination therapies in acute ischemic stroke, utilizing a network meta-analysis. Methods: Patients receiving different MT devices (MERCI, TREVO, Solitaire, Penumbra, or a combination of MT devices) were compared to standard care, intravenous thrombolysis (IVT), or intra-arterial thrombolysis (IAT) for AIS treatment. Safety outcomes included symptomatic intracranial hemorrhage (sICH) and all-cause mortality at 90 days. Efficacy outcomes were good functional recovery at 90 days (defined as a modified Rankin Scale score of 0-2) and successful recanalization (measured by a TICI score of 2b-3). Results: We included 201 studies, comprising 43 RCTs and 159 cohort studies with 71,154 AIS patients. The TREVO device demonstrated the highest efficacy for functional recovery (OR = 3.63, 95% CrI: 2.45-5.43), followed by MT + IVT (OR = 2.87, CrI: 2.30-3.59). TREVO also achieved the highest rate of successful recanalization (OR = 3.35, CrI: 1.36-8.19). The MERCI, Solitaire, and aspiration devices were associated with a higher risk of sICH. For all-cause mortality at 90 days, the TREVO device notably reduced the odds (OR = 0.56, CrI: 0.37-0.86), whereas aspiration devices showed no significant difference from standard treatments. Conclusion: Our findings demonstrate that contemporary stent-retriever device technology is the most effective option for improving functional recovery, achieving successful recanalization, and reducing mortality in AIS patients. These results highlight the critical need for selecting the most effective and safest thrombectomy device to optimize outcomes in acute stroke care.
Neurology
What problem does this paper attempt to address?